TigerYeah Capital Fund

TigerYeah Capital is a healthcare-focused venture capital firm based in Hangzhou, China, and is closely affiliated with Hangzhou Tigermed Consulting, a leading global Clinical Research Organization (CRO). The fund specializes in identifying and supporting high-potential startups across the biotechnology, pharmaceutical, and medical device sectors. By leveraging the clinical trial infrastructure and regulatory expertise of Tigermed, TigerYeah Capital provides significant strategic value and operational support to its portfolio companies. The firm invests across various stages of development, from early-stage research to growth-stage commercial expansion. Its portfolio includes a diverse range of innovative companies working on cutting-edge therapies, in vitro diagnostics, and digital health solutions. TigerYeah Capital aims to foster a robust healthcare ecosystem by accelerating the path to market for transformative medical innovations.